Bladder sparing approach for initial T1G3 bladder cancer: Do multifocality, size of tumor or concomitant carcinoma in situ matter? A long-term analysis of 132 patients
Author:
Publisher
Wiley
Subject
Urology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1442-2042.2007.01890.x/fullpdf
Reference20 articles.
1. Contemporary management of stage T1 transitional cell carcinoma of the bladder;Soloway;J. Urol.,2002
2. Maintenance bacillus Calmette-Guerin immunotherapy for recurrent TA, T1 and carcinoma in situ transitional cell carcinoma of the bladder: A randomized Southwest Oncology Group Study;Lamm;J. Urol.,2002
3. Substaging of T1 bladder carcinoma based on the depth of invasion as measured by micrometer: A new proposal;Cheng;Cancer,1999
4. The biological characteristics of T1G3 bladder tumours are the same as muscle invasive cancer: A study of cell proliferation and molecular markers of aggressiveness;Sriprasad;J. Urol.,2001
5. Initial high-grade T1 urothelial cell carcinoma: Feasibility and prognostic significance of lamina propria invasion microstaging (T1a/b/c) in BCG-treated and BCG-non-treated patients;Orsola;Eur. Urol.,2005
Cited by 25 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Sub-Staging-Specific Differences in Recurrence-Free, Progression-Free, and Cancer-Specific Survival for Patients with T1 Bladder Cancer: A Systematic Review and Meta-Analysis;Urologia Internationalis;2020
2. Predictors of Oncologic Outcomes After Treatment of Urothelial Cancer;International Manual of Oncology Practice;2019
3. Clinical significance of random bladder biopsy in primary T1 bladder cancer;Molecular and Clinical Oncology;2018-03-08
4. Risk Factors for Recurrence and Progression of Nonmuscle Invasive Bladder Cancer;Bladder Cancer;2018
5. Lymphovascular invasion status at transurethral resection of bladder tumors may predict subsequent poor response of T1 tumors to bacillus Calmette-Guérin;BMC Urology;2016-01-19
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3